343 related articles for article (PubMed ID: 24114037)
1. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.
Cleeland CS; Zhao F; Chang VT; Sloan JA; O'Mara AM; Gilman PB; Weiss M; Mendoza TR; Lee JW; Fisch MJ
Cancer; 2013 Dec; 119(24):4333-40. PubMed ID: 24114037
[TBL] [Abstract][Full Text] [Related]
2. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
[TBL] [Abstract][Full Text] [Related]
3. The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.
Armstrong TS; Vera-Bolanos E; Acquaye AA; Gilbert MR; Ladha H; Mendoza T
Neuro Oncol; 2016 Feb; 18(2):252-60. PubMed ID: 26289592
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Amharic Version of the M. D. Anderson Symptom Inventory and Assessment of Symptoms in Ethiopian Cancer Patients.
Anshabo AT; Migbaru S; Mulu A; Negusu D; Asfaw AA; Awoke D; Tigeneh W; Engidawork E
J Pain Symptom Manage; 2016 May; 51(5):947-53. PubMed ID: 26988847
[TBL] [Abstract][Full Text] [Related]
5. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.
Schmidt H; Cleeland CS; Bauer A; Landenberger M; Jahn P
J Pain Symptom Manage; 2015 Jan; 49(1):117-25. PubMed ID: 24858739
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
[TBL] [Abstract][Full Text] [Related]
7. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
George GC; Iwuanyanwu EC; Anderson KO; Yusuf A; Zinner RG; Piha-Paul SA; Tsimberidou AM; Naing A; Fu S; Janku F; Subbiah V; Cleeland CS; Mendoza TR; Hong DS
Cancer; 2016 Nov; 122(21):3401-3409. PubMed ID: 27412379
[TBL] [Abstract][Full Text] [Related]
8. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
[TBL] [Abstract][Full Text] [Related]
9. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group.
Jones D; Zhao F; Fisch MJ; Wagner LI; Patrick-Miller LJ; Cleeland CS; Mendoza TR
Clin Genitourin Cancer; 2014 Feb; 12(1):41-9. PubMed ID: 24126238
[TBL] [Abstract][Full Text] [Related]
10. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
Albaba H; Barnes TA; Veitch Z; Brown MC; Shakik S; Su S; Naik H; Wang T; Liang M; Perez-Cosio A; Eng L; Mittmann N; Xu W; Howell D; Liu G
Oncologist; 2019 Nov; 24(11):e1219-e1227. PubMed ID: 31409744
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.
Wang XS; Zhao F; Fisch MJ; O'Mara AM; Cella D; Mendoza TR; Cleeland CS
Cancer; 2014 Feb; 120(3):425-32. PubMed ID: 24436136
[TBL] [Abstract][Full Text] [Related]
13. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.
Sailors MH; Bodurka DC; Gning I; Ramondetta LM; Williams LA; Mendoza TR; Agarwal S; Sun CC; Cleeland CS
Gynecol Oncol; 2013 Aug; 130(2):323-8. PubMed ID: 23685012
[TBL] [Abstract][Full Text] [Related]
14. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
Gabrilove JL; Perez EA; Tomita DK; Rossi G; Cleeland CS
Cancer; 2007 Oct; 110(7):1629-40. PubMed ID: 17694552
[TBL] [Abstract][Full Text] [Related]
15. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
16. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
[TBL] [Abstract][Full Text] [Related]
17. Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study.
Mendoza TR; Kehl KL; Bamidele O; Williams LA; Shi Q; Cleeland CS; Simon G
Support Care Cancer; 2019 Sep; 27(9):3439-3447. PubMed ID: 30661202
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
Nyrop KA; Deal AM; Shachar SS; Basch E; Reeve BB; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Oncologist; 2019 Jun; 24(6):762-771. PubMed ID: 30552158
[TBL] [Abstract][Full Text] [Related]
19. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients.
Wang XS; Wang Y; Guo H; Mendoza TR; Hao XS; Cleeland CS
Cancer; 2004 Oct; 101(8):1890-901. PubMed ID: 15386315
[TBL] [Abstract][Full Text] [Related]
20. Differences in Symptom Burden Among Cancer Patients With Different Stages of Cachexia.
Zhou T; Yang K; Thapa S; Liu H; Wang B; Yu S
J Pain Symptom Manage; 2017 May; 53(5):919-926. PubMed ID: 28062340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
